Building Better Bioadhesives

A WPI researcher is developing a new class of medical adhesives by bringing together hydrogels and glue-like polymers to safely and reliably connect human tissues to therapeutic devices implanted in the body, such as pacemakers, insulin pumps, and artificial joints.

Jiawei Yang, an assistant professor in the Department of Mechanical and Materials Engineering who is affiliated with the Department of Biomedical Engineering, has received a prestigious $644,659 CAREER Award from the National Science Foundation to create bioadhesives that can provide strong, stable adhesion and comply with the mechanical demands on biological tissues.

“Medical devices and human beings are made of very different materials,” says Yang. “Medical devices are mostly made of hard materials, such as metal or plastic. Human tissue is generally soft and wet. There is a critical need for better adhesives that are soft and wet, like human tissues, to knit together tissues and devices. Better adhesives can work better with the body and would significantly improve healthcare and quality of life for patients.”

Yang will develop bioadhesives with two layers—a transparent solid hydrogel layer and a clear liquid adhesive layer. He will develop a modular system of hydrogels that are tailored to the mechanical properties of target tissues and polymers that can merge with human tissues. Together, the hydrogel-polymer bioadhesives will provide fast, strong, stable, and deep adhesion in the body.

As part of his five-year project, Yang will collaborate with Dr. Steffen Pabel at Massachusetts General Hospital to develop a hydrogel heart patch loaded with medications to treat atrial fibrillation, a type of irregular heartbeat. He also will create education and research programs about hydrogels for children and college students. PhD student Jiatai Sun is working on the project with Yang.

“There are many potential applications for new bioadhesives,” Yang says. “They might be used to pair with electrodes that are implanted in the body to treat Parkinson’s disease or manage and treat heart failure. They also could be combined with therapeutic agents to heal damaged cartilage or generate healthy new tissues.”